This contract will support component a of the collaborative influenza vaccine innovation centers (civics) program to design and evaluate innovative influenza vaccine approaches, based on principles of…
Active Definitive Contract Awarded Last action
- Contract number
- 75N93019C00050
- Awardee
-
Duke University UEI TP7EK8DZV6N5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $67,973,443
Award facts
- Opportunity
-
- HHSNIHNIAIDBAA2018 Solicitation number
- Research Area 003 - Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases Award Notice · Posted Jun 1, 2018
- Contract value 58% obligated
-
- $67,973,442.64 Current, with exercised options
- $116,438,778.64 Potential, with all options
- Completion date 90% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 9 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Durham, NC 27705, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$205,735 | |
| Exercise an Option | $577,876 | |
| Exercise an Option | $1,057,690 | |
| Supplemental Agreement for work within scope | $7,914,242 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | -$2,073 | |
| Exercise an Option | $79,658 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $1,501,082 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $625,965 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $7,985,177 | |
| Exercise an Option | $10,067,941 | |
| Exercise an Option | $625,965 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $257,692 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $1,776,150 | |
| Exercise an Option | $9,162,778 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $10,350,147 | |
| Exercise an Option | $799,998 | |
| Exercise an Option | $515,384 | |
| Supplemental Agreement for work within scope | -$1,787,684 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $8,741,423 | |
| Original award | $7,929,767 |
Show all 34
About this award
The National Institute of Allergy and Infectious Diseases awarded a $116.4 million definitive contract to Duke University for design and evaluation of innovative influenza vaccine approaches under the Collaborative Influenza Vaccine Innovation Centers (CIVICS) Component A program, with an ultimate completion date of July 28, 2027.
The contract carries no set-aside designation and is priced on a cost, no-fee basis. Work is performed in Durham, North Carolina. The program supports development of durable, robust influenza vaccine candidates based on principles of influenza immunity. Duke University's Office of Research Administration serves as the awardee.
Subcontractors include the University of Pennsylvania (mRNA vaccine development and immunogenicity optimization), the University of Pittsburgh (nucleic acid-vectored hemagglutinin constructs and immunogenicity evaluation), the University of Texas at Austin (B-cell and serological antibody repertoire analysis via high-throughput sequencing), Boston Children's Hospital (immunogen design and structural characterization), Massachusetts General Hospital (hemagglutinin-based immunogen design), and Najit Technologies Inc. (HydroVax vaccine platform development).
Service Contract Inventory data shows actual government-invoiced labor totaling $27.6 million across FY2020–FY2025, with the most recent reported fiscal year (FY2025) delivering 28.0 FTEs. Derived government-paid hourly rates rose from $37.71/hr in FY2022 to $497.27/hr in FY2024, reflecting a shift toward senior-level scientific effort. The prime performed all reported hours in FY2025 without subcontractor involvement on invoiced labor.
Description
This contract will support component a of the collaborative influenza vaccine innovation centers (civics) program to design and evaluate innovative influenza vaccine approaches, based on principles of influenza immunity, that achieve durable, robust
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| The Trustees Of The University Of Pennsylvania | $384,749 | |
| University Of Pittsburgh - Of The Commonwealth System Of Higher Education | $384,749 | |
| The Trustees Of The University Of Pennsylvania | $384,749 | |
| University Of Pittsburgh - Of The Commonwealth System Of Higher Education | $384,274 | |
| University Of Texas At Austin | $199,852 | |
| The General Hospital Corporation | $424,585 | |
| University Of Texas At Austin | $199,852 | |
| The Children's Hospital Corporation | $424,927 | |
| The Trustees Of The University Of Pennsylvania | $1,512,029 | |
| Najit Technologies, Inc. | $384,430 | |
| The General Hospital Corporation | $424,585 | |
| The Trustees Of The University Of Pennsylvania | $1,499,639 | |
| The Children's Hospital Corporation | $424,927 |
Show all 13
Quick answers
Who was awarded contract 75N93019C00050?
75N93019C00050 was awarded to Duke University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 10, 2019.
How much is contract 75N93019C00050 worth?
The government has obligated $67,973,443 on 75N93019C00050. Its potential value, with all options, is $116,438,779.
Was contract 75N93019C00050 competed?
The extent of competition for 75N93019C00050 was full and open competition. The government received 9 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award